Baudette, MN – September 21, 2015 – ANI Pharmaceuticals, Inc. (“ANI”) (NASDAQ: ANIP) today announced that it has agreed to acquire the NDAs for purified corticotropin gel and corticotropin zinc hydroxide from Merck (known as MSD outside of the United States and Canada) for $75 million in cash and a percentage of future net sales.Read more >
Baudette, MN – December 5, 2014 – ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) (the “Company”) today announced the pricing of an underwritten public offering of $125,000,000 aggregate principal amount of its 3.00% Convertible Senior Notes due 2019 (the “Notes”). The aggregate principal offering amount was increased from the previously announced offering size of $100,000,000. The underwriters have a 30-day option toRead more >
BAUDETTE, Minn., March 10, 2014 — ANI Pharmaceuticals, Inc. (the “Company”) (ANIP), today announced the closing of its previously announced underwritten public offering of 1,612,903 shares of common stock, at a price to the public of $31.00 per share and for gross proceeds of $50.0 million. The shares include 210,378 shares of common stock soldRead more >
BAUDETTE, Minn., Dec. 26, 2013 – ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), an emerging generic pharmaceutical company, today announced that it has acquired 31 previously marketed generic drug products from Teva Pharmaceuticals for $12.5 million in cash and a percentage of future gross profits from product sales. The acquisition includes 20 solid-oral immediate release products, 4Read more >
BAUDETTE, Minn.–(BUSINESS WIRE)– BioSante Pharmaceuticals, Inc. (BPAX) announced today that it has completed the merger of its wholly-owned subsidiary with and into ANIP Acquisition Company d/b/a ANI Pharmaceuticals, Inc. (ANI) in accordance with the terms of the amended and restated agreement and plan of merger, dated as of April 12, 2013. In connection with theRead more >
BioSante Pharmaceuticals and ANI Pharmaceuticals Announce Merger Combined Company Will Focus on Specialty Branded and Generic Pharmaceutical Product Development, Manufacturing and Sales LINCOLNSHIRE, Illinois and Baudette, Minnesota (October 4, 2012) – BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) and ANIP Acquisition Company d/b/a ANI Pharmaceuticals, Inc. announced today that they have entered into a definitive merger agreementRead more >
